ADVERTISEMENT
Search

Pharmacy News

FDA warns of dental problems associated with certain buprenorphine medications

FDA is drawing attention to dental problems linked to buprenorphine-containing medications that are dissolved under the tongue or placed against the inside of the cheek to treat opioid use disorder and pain.

Many patients not receiving statins after lower-extremity revascularization

A new study in JAMA Network Open analyzed data from more than 125,000 patients who received lower-extremity revascularization between 2014 and 2019.

Study links statins with more aggressive diabetes progression

Patients with diabetes who used statins experienced less control of their diabetes than patients who did not take statins, suggests a new retrospective study published in JAMA Internal Medicine.

Fentanyl deaths spike in certain parts of the U.S.

Between 2019 and 2020, illicitly manufactured fentanyl-related overdose deaths increased substantially in western, southern, and midwestern states, CDC reported.

FDA puts clozapine REMS requirements on temporary hold

FDA said it is temporarily halting its risk evaluation and mitigation strategy (REMS) program for clozapine, a treatment for schizophrenia.

RSS
First3536373840424344Last
ADVERTISEMENT